Infinity Pharmaceuticals Stock Analysis
| INFIQ Stock | 0.0001 0.00 0.00% |
Infinity Pharmaceuticals is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Infinity Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Infinity Pharmaceuticals is worth, separate from its market price. There are two main types of Infinity Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Infinity Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Infinity Pharmaceuticals is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Infinity Stock trading window is adjusted to America/New York timezone.
Infinity |
Infinity Stock Analysis Notes
The company recorded a loss per share of 0.46. Infinity Pharmaceuticals had not issued any dividends in recent years. The entity had 1:4 split on the 13th of September 2006. To learn more about Infinity Pharmaceuticals call Seth JD at 617 453 1000 or check out https://www.infi.com.Infinity Pharmaceuticals Quarterly Total Revenue |
|
Infinity Pharmaceuticals Investment Alerts
| Infinity Pharmaceuticals generated a negative expected return over the last 90 days | |
| Infinity Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Infinity Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 2.59 M. Net Loss for the year was (44.37 M) with loss before overhead, payroll, taxes, and interest of (31.38 M). | |
| Infinity Pharmaceuticals generates negative cash flow from operations | |
| Latest headline from investing.com: Earnings call Agilent Technologies reports modest growth in Q4 |
Infinity Largest EPS Surprises
Earnings surprises can significantly impact Infinity Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-02 | 2021-09-30 | -0.1382 | -0.12 | 0.0182 | 13 | ||
2020-03-03 | 2019-12-31 | -0.19 | -0.21 | -0.02 | 10 | ||
2021-05-13 | 2021-03-31 | -0.125 | -0.15 | -0.025 | 20 |
Infinity Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.08 K.Infinity Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.95) | (0.99) | |
| Return On Capital Employed | (1.81) | (1.90) | |
| Return On Assets | (0.95) | (0.99) | |
| Return On Equity | 2.10 | 2.20 |
Management Efficiency
Infinity Pharmaceuticals has return on total asset (ROA) of (0.607) % which means that it has lost $0.607 on every $100 spent on assets. This is way below average. Infinity Pharmaceuticals' management efficiency ratios could be used to measure how well Infinity Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/30/2024, Return On Equity is likely to grow to 2.20, while Return On Tangible Assets are likely to drop (0.99). As of 11/30/2024, Liabilities And Stockholders Equity is likely to grow to about 59.2 M, while Total Current Liabilities is likely to drop slightly above 13.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.25) | (0.23) | |
| Tangible Book Value Per Share | (0.25) | (0.23) | |
| Enterprise Value Over EBITDA | (0.25) | (0.26) | |
| Price Book Value Ratio | (2.99) | (2.84) | |
| Enterprise Value Multiple | (0.25) | (0.26) | |
| Price Fair Value | (2.99) | (2.84) | |
| Enterprise Value | 14 M | 13.3 M |
The operational strategies employed by Infinity Pharmaceuticals management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Operating Margin (17.36) | Beta 1.334 | Return On Assets (0.61) |
Technical Drivers
Infinity Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Infinity Pharmaceuticals Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Infinity Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Infinity Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Infinity Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Infinity Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Infinity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Infinity Pharmaceuticals. By using and applying Infinity Stock analysis, traders can create a robust methodology for identifying Infinity entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (19.68) | (20.66) | |
| Operating Profit Margin | (19.89) | (20.88) | |
| Net Loss | (19.68) | (20.66) | |
| Gross Profit Margin | 0.36 | 0.38 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Infinity Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.